Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Handok Pharmaceuticals Co. Ltd.

www.handok.co.kr

Latest From Handok Pharmaceuticals Co. Ltd.

Finance Watch: Recent Offerings Show Some Companies Were Ready For The Government Shutdown

Public Company Edition: The usual mid-January surge in public offerings hasn't happened this year, since the SEC can't process new filings, but Alnylam, Acceleron and others apparently were prepared for a lengthy shutdown. Also, ARM reports cell and gene therapy financing data.

Financing Business Strategies

1ST Bio Bets On BBB-Penetrating C-ABL Inhibitor As Potential Disease-Modifying Parkinson's Drug

Emerging Company Profile: 1ST Biotherapeutics CEO highlights its lead candidate program – a novel small molecule c-Abl inhibitor, which touts superior blood-brain penetration and selectivity – for its potential to become a disease-modifying drug for Parkinson's disease.

South Korea StartUps and SMEs

Pipeline Watch: Phase III Starts With Filgotinib, Gilteritinib And Nivolumab

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

Pipeline Watch Clinical Trials

Genexine Seeks China Entry Through Multi-Biologic Tasly Tie-Up

South Korean biotech firm Genexine is broadening its presence in Asia. Following an agreement earlier this month with Kalbe Farma to set up a joint venture in Indonesia, it has now signed a licensing out deal for protein therapies with a subsidiary of China’s Tasly Pharmaceutical.

BioPharmaceutical China
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Glucose Testing
  • Medical Devices
    • Monitoring Equipment & Devices
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
    • Vaccines
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • Handok Pharmaceuticals Co. Ltd.
  • Senior Management
  • Young-jin Kim, Chmn. & CEO
    Woo-Ick Jang, MD, PhD, Head, R&D
    Jang-Sik Jung, Head, Sales
    Yong-Min Won, Head, Fin.
  • Contact Info
  • Handok Pharmaceuticals Co. Ltd.
    Phone: (82) 2 527 5114
    132 Teheran St.
    Gangnam-Gu
    Seoul, 135-755
    South Korea
Advertisement
Advertisement
UsernamePublicRestriction

Register